9 results
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... , a half B-profile ... BLUE #protocol #Algorithm ... #Dyspnea #CriticalCare ... #POCUS #Lung #Pulmonary
Dyspnea - Considerations with Malignancy
Directly Malignancy Related:
 - Lymphangitic spread to lung
 - Malignant pleural effusion
Dyspnea - Considerations ... Lymphangitic spread to lung ... #algorithm #differential ... #diagnosis #oncology ... #cancer #malignancy
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... with lung-rockets ... B profile is a half ... , a half B-profile ... www.grepmed.com/images/11924/dyspnea-criticalcare-pulmonary-algorithm-pocus
Causes of Dyspnea - Differential Diagnosis Algorithm
Cardiac:
 • Dysrhythmia
 • Ischemia
 • Cardiomyopathy
 • Valvular disease
Causes of Dyspnea ... Differential Diagnosis Algorithm ... Emphysema • Cancer ... • Interstitial lung ... amzn.to/2LmUODZ #Dyspnea
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
- performed on dyspneic ... , a half B-profile ... BLUE #protocol #Algorithm ... #Dyspnea #CriticalCare ... #POCUS #Lung #Pulmonary
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... thrombosis; PE = pulmonary ... #Algorithm #Anticoagulation ... #Management #Hematology ... #Oncology
Causes of Localized Lymphadenopathy - Differential Diagnosis Algorithm
Cervical:
 - Anterior
     • Infection
Differential Diagnosis Algorithm ... , Mediastinum, Lungs ... , Breast) • Cancer ... #Causes #Hematology ... #Oncology
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
goals of assessing lung ... and relief of dyspnea ... the patient’s dyspnea ... #Algorithm #Effusion ... Management #Pleural #Pulmonary
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... From Blood Cancer ... cardiovascular or pulmonary ... Network (NCCN) guidelines ... #algorithm #hematology